Sutro Biopharma Stock Forecast - Naive Prediction
| STRO Stock | USD 12.73 0.07 0.55% |
The Naive Prediction forecasted value of Sutro Biopharma on the next trading day is expected to be 12.37 with a mean absolute deviation of 0.47 and the sum of the absolute errors of 28.46. Sutro Stock Forecast is based on your current time horizon. Although Sutro Biopharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Sutro Biopharma's systematic risk associated with finding meaningful patterns of Sutro Biopharma fundamentals over time.
As of today the rsi of Sutro Biopharma's share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.28) | EPS Estimate Current Year (1.94) | EPS Estimate Next Year (1.17) | Wall Street Target Price 2.6857 | EPS Estimate Current Quarter (0.33) |
Using Sutro Biopharma hype-based prediction, you can estimate the value of Sutro Biopharma from the perspective of Sutro Biopharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Sutro Biopharma using Sutro Biopharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Sutro using crowd psychology based on the activity and movement of Sutro Biopharma's stock price.
Sutro Biopharma Short Interest
An investor who is long Sutro Biopharma may also wish to track short interest. As short interest increases, investors should be becoming more worried about Sutro Biopharma and may potentially protect profits, hedge Sutro Biopharma with its derivative instruments, or be ready for some potential downside.
200 Day MA 0.9827 | Short Percent 0.0401 | Short Ratio 2.37 | Shares Short Prior Month 560.3 K | 50 Day MA 0.941 |
Sutro Biopharma Hype to Price Pattern
Investor biases related to Sutro Biopharma's public news can be used to forecast risks associated with an investment in Sutro. The trend in average sentiment can be used to explain how an investor holding Sutro can time the market purely based on public headlines and social activities around Sutro Biopharma. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Sutro Biopharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Sutro Biopharma.
Sutro Biopharma Implied Volatility | 1.55 |
Sutro Biopharma's implied volatility exposes the market's sentiment of Sutro Biopharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Sutro Biopharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Sutro Biopharma stock will not fluctuate a lot when Sutro Biopharma's options are near their expiration.
The Naive Prediction forecasted value of Sutro Biopharma on the next trading day is expected to be 12.37 with a mean absolute deviation of 0.47 and the sum of the absolute errors of 28.46. Sutro Biopharma after-hype prediction price | USD 12.61 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Sutro Biopharma to cross-verify your projections. Open Interest Against 2026-02-20 Sutro Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Sutro Biopharma's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Sutro Biopharma's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Sutro Biopharma stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Sutro Biopharma's open interest, investors have to compare it to Sutro Biopharma's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Sutro Biopharma is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Sutro. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Sutro Biopharma Additional Predictive Modules
Most predictive techniques to examine Sutro price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sutro using various technical indicators. When you analyze Sutro charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sutro Biopharma Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Sutro Biopharma's financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2016-12-31 | Previous Quarter 64 M | Current Value 65.9 M | Quarterly Volatility 61.7 M |
Sutro Biopharma Naive Prediction Price Forecast For the 16th of January 2026
Given 90 days horizon, the Naive Prediction forecasted value of Sutro Biopharma on the next trading day is expected to be 12.37 with a mean absolute deviation of 0.47, mean absolute percentage error of 0.33, and the sum of the absolute errors of 28.46.Please note that although there have been many attempts to predict Sutro Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Sutro Biopharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Sutro Biopharma Stock Forecast Pattern
| Backtest Sutro Biopharma | Sutro Biopharma Price Prediction | Buy or Sell Advice |
Sutro Biopharma Forecasted Value
In the context of forecasting Sutro Biopharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Sutro Biopharma's downside and upside margins for the forecasting period are 5.45 and 19.30, respectively. We have considered Sutro Biopharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Sutro Biopharma stock data series using in forecasting. Note that when a statistical model is used to represent Sutro Biopharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.0166 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.4665 |
| MAPE | Mean absolute percentage error | 0.0484 |
| SAE | Sum of the absolute errors | 28.4583 |
Predictive Modules for Sutro Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sutro Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Sutro Biopharma
For every potential investor in Sutro, whether a beginner or expert, Sutro Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sutro Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sutro. Basic forecasting techniques help filter out the noise by identifying Sutro Biopharma's price trends.Sutro Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sutro Biopharma stock to make a market-neutral strategy. Peer analysis of Sutro Biopharma could also be used in its relative valuation, which is a method of valuing Sutro Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Sutro Biopharma Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Sutro Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Sutro Biopharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sutro Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Sutro Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sutro Biopharma shares will generate the highest return on investment. By undertsting and applying Sutro Biopharma stock market strength indicators, traders can identify Sutro Biopharma entry and exit signals to maximize returns.
Sutro Biopharma Risk Indicators
The analysis of Sutro Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sutro Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sutro stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.52 | |||
| Semi Deviation | 5.08 | |||
| Standard Deviation | 7.07 | |||
| Variance | 50.0 | |||
| Downside Variance | 31.81 | |||
| Semi Variance | 25.85 | |||
| Expected Short fall | (6.94) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Sutro Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sutro Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sutro Biopharma will appreciate offsetting losses from the drop in the long position's value.Moving against Sutro Stock
The ability to find closely correlated positions to Sutro Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sutro Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sutro Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sutro Biopharma to buy it.
The correlation of Sutro Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sutro Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sutro Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sutro Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Sutro Biopharma to cross-verify your projections. To learn how to invest in Sutro Stock, please use our How to Invest in Sutro Biopharma guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sutro Biopharma. If investors know Sutro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sutro Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.60) | Revenue Per Share | Quarterly Revenue Growth 0.138 | Return On Assets | Return On Equity |
The market value of Sutro Biopharma is measured differently than its book value, which is the value of Sutro that is recorded on the company's balance sheet. Investors also form their own opinion of Sutro Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sutro Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sutro Biopharma's market value can be influenced by many factors that don't directly affect Sutro Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sutro Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sutro Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sutro Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.